Видео ютуба по тегу Azurrx

James Sapirstein, President and CEO at AzurRx BioPharma
James Sapirstein, President and CEO at AzurRx BioPharma
Thjis Spoor from AzurRx Biopharma on CEO Money
Thjis Spoor from AzurRx Biopharma on CEO Money
AzurRX (AZRX) recap of 2016 company highlights
AzurRX (AZRX) recap of 2016 company highlights
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
Azurrx BioPharma: a clinical stage biopharmaceutical company
Azurrx BioPharma: a clinical stage biopharmaceutical company
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
FMW Media - AzurRx BioPharma
FMW Media - AzurRx BioPharma
💵 IS AZRX A BUY OR SELL? I AzurRx Stock I Azur Rx predictions I PREDICTION news analyst analysis
💵 IS AZRX A BUY OR SELL? I AzurRx Stock I Azur Rx predictions I PREDICTION news analyst analysis
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
The Richmond Club Stock Pick - AzurRx Biopharma #shorts
The Richmond Club Stock Pick - AzurRx Biopharma #shorts
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
Thijs Spoor of AzurRx Provides a Company Overview
Thijs Spoor of AzurRx Provides a Company Overview
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
AzurRx BioPharma Presentation at Investor Summit Group’s Q2 Virtual Investor Summit
AzurRx BioPharma Presentation at Investor Summit Group’s Q2 Virtual Investor Summit
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.